BioAge Labs, Inc. (BIOA)
16.57
+0.38
(+2.35%)
USD |
NASDAQ |
Apr 14, 16:00
16.55
-0.02
(-0.12%)
After-Hours: 04:52
BioAge Labs EPS Diluted (Quarterly) : -0.7185 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| Plus Therapeutics, Inc. | -1.03 |
| BioStem Technologies, Inc. | -0.67 |
| Iovance Biotherapeutics, Inc. | -0.1767 |
| Protokinetix, Inc. | -0.0002 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.94M |
| Revenue (Quarterly) | 3.078M |
| Total Expenses (Quarterly) | 29.02M |
| Enterprise Value | 459.84M |
| Gross Profit Margin (Quarterly) | 97.76% |
| Profit Margin (Quarterly) | -842.9% |
| Earnings Yield | -13.54% |
| Normalized Earnings Yield | -13.51 |